Glandore's Michael Kelly increases his stake in Poolbeg Pharma – The Irish Times
Most recent acquisition makes managing director the company’s second-largest shareholder after founder Cathal Friel
Stay updated with breaking news from Amryt Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Most recent acquisition makes managing director the company’s second-largest shareholder after founder Cathal Friel
Amryt Pharma plc (LON:AMYT – Get Free Report) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 143 ($1.80) and traded as low as GBX 143 ($1.80). Amryt Pharma shares last traded at GBX 143 ($1.80), with a volume of 90,727 […]
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in ...
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug ...
Company signs strategic collaboration agreement with a Nasdaq listed biopharma company